Announcement
03 May 2020
In May 2020, the government of Canada announced providing funding to AbCellera Biologics to support the company’s investment in antibody discovery technology to treat COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
03 May 2020
Revocation date:
No revocation date
Updated: 03 May 2020
State loan
In force
On 3 May 2020, the government of Canada announced providing CAD 175 million (USD 124.6 million) to AbCellera Biologics through the strategic innovation fund to support AbCellera’s investment in antibo...
Sign in to see more
Related State Acts
24 May 2023
Canada: Federal and British Columbia governments investing CAD 300 million in AbCellera
18 May 2021
Canada: Government announces funding for a Canadian biomanufacturing company
23 Mar 2020
Canada: Government allocates CAD 792 million for the development and production of medical countermeasures to COVID-19
Threads
See all
This state act is not part of any Thread yet.